Evelo Biosciences, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2020 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Evelo Biosciences, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2020 to Q3 2023.
  • Evelo Biosciences, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2023 was 17.4M shares, a 222% increase year-over-year.
  • Evelo Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 87.2M shares, a 64.7% increase from 2021.
  • Evelo Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 52.9M shares, a 34% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 17.4M +12M +222% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 5.58M +1.79M +47.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 111M +57.3M +107% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 87.2M +34.3M +64.7% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-16
Q3 2022 5.4M -48M -89.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 3.79M -49.6M -92.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 53.6M +2.28M +4.43% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 52.9M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 53.4M +7.26M +15.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 53.4M +20.7M +63.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 51.3M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 46.2M Jul 1, 2020 Sep 30, 2020 10-Q/A 2021-10-29
Q2 2020 32.6M Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.